… Martin Bendszus coordinated the study and contributed to the study design, data collection,
and analysis, and the writing of the paper. Martin Koltzenburg contributed to the study design…

Methods A hybrid approach based on established processes described by Glaser15 and by
the National Institutes of Health (http://prevention. nih. gov/cdp/about. aspx) 16 was used to …

The European Association for Neuro-Oncology guideline provides recommendations for the
clinical care of adult patients with astrocytic and oligodendroglial gliomas, including …

Background Bevacizumab is approved for the treatment of patients with progressive glioblastoma
on the basis of uncontrolled data. Data from a phase 2 trial suggested that the addition …

Background and Purpose— The simplistic view of atherosclerosis as a disorder of
pathological lipid deposition has been redefined by the more complex concept of an ongoing …

Background Haematoma expansion is a major cause of mortality in intracranial haemorrhage
related to vitamin K antagonists (VKA-ICH). Normalisation of the international normalised …

In response to major changes in diagnostic algorithms and the publication of mature results
from various large clinical trials, the European Association of Neuro-Oncology (EANO) …

Accurate pathological diagnosis is crucial for optimal management of patients with cancer.
For the approximately 100 known tumour types of the central nervous system, standardization …

Gliomas are the most common primary brain malignancies, with different degrees of
aggressiveness, variable prognosis and various heterogeneous histologic sub-regions, ie, …

CNS metastases are the most common cause of malignant brain tumours in adults. Historically,
patients with brain metastases have been excluded from most clinical trials, but their …